DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$56.1B
1-Year Return
19.33%
This Quarter Return
+10.04%
1 Year Return
+19.33%
3 Year Return
+93.16%
5 Year Return
+155.59%
10 Year Return
+349.91%
AUM
$39.7B
AUM Growth
+$1.93B
(+5.1%)
Cap. Flow
-$130M
Cap. Flow
% of AUM
-0.33%
Top 10 Holdings %
Top 10 Hldgs %
22.97%
Holding
1,397
New
55
Increased
565
Reduced
428
Closed
92
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$111M |
| 2 |
Chevron
CVX
|
+$108M |
| 3 |
Skyworks Solutions
SWKS
|
+$102M |
| 4 |
Microsoft
MSFT
|
+$73.9M |
| 5 |
Broadcom
AVGO
|
+$64.6M |
Top Sells
| 1 |
Linde
LIN
|
+$796M |
| 2 |
Parker-Hannifin
PH
|
+$102M |
| 3 |
NVIDIA
NVDA
|
+$93.6M |
| 4 |
Exxon Mobil
XOM
|
+$86.8M |
| 5 |
PNC Financial Services
PNC
|
+$72.7M |
Sector Composition
| 1 | Technology | 27.97% |
| 2 | Healthcare | 18.51% |
| 3 | Financials | 10.57% |
| 4 | Industrials | 9.29% |
| 5 | Consumer Discretionary | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
926
Ovintiv
OVV
$11B
| $783K | ﹤0.01% |
22,511
-5,880
| -21% | -$205K |
|
927
Pliant Therapeutics
PLRX
$104M
| $782K | ﹤0.01% |
+30,000
| New | +$782K |
|
928
SITE Centers
SITC
$468M
| $781K | ﹤0.01% |
85,304
-70,629
| -45% | -$647K |
|
929
Aramark
ARMK
$10B
| $778K | ﹤0.01% |
31,178
+1,050
| +3% | +$26.2K |
|
930
Sweetgreen
SG
$1.03B
| $773K | ﹤0.01% |
97,700
| – | – |
|
931
TechnipFMC
FTI
$16.8B
| $771K | ﹤0.01% |
58,000
-108,300
| -65% | -$1.44M |
|
932
uniQure
QURE
$959M
| $767K | ﹤0.01% |
39,400
| – | – |
|
933
Coupang
CPNG
$58.6B
| $765K | ﹤0.01% |
48,710
+2,048
| +4% | +$32.2K |
|
934
Kinross Gold
KGC
$28B
| $761K | ﹤0.01% |
162,487
+46,978
| +41% | +$220K |
|
935
Pacific Biosciences
PACB
$366M
| $747K | ﹤0.01% |
73,300
| – | – |
|
936
Tencent Music
TME
$39.2B
| $739K | ﹤0.01% |
89,235
+8,690
| +11% | +$72K |
|
937
DaVita
DVA
$9.46B
| $738K | ﹤0.01% |
9,360
-20,336
| -68% | -$1.6M |
|
938
Coherus Oncology, Inc. Common Stock
CHRS
$152M
| $737K | ﹤0.01% |
116,600
| – | – |
|
939
Arbutus Biopharma
ABUS
$886M
| $734K | ﹤0.01% |
250,000
| – | – |
|
940
Broadstone Net Lease
BNL
$3.52B
| $729K | ﹤0.01% |
43,848
+6,471
| +17% | +$108K |
|
941
Ormat Technologies
ORA
$5.51B
| $727K | ﹤0.01% |
8,657
+4,315
| +99% | +$362K |
|
|
MRTX
942
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $726K | ﹤0.01% |
20,000
| – | – |
|
943
Texas Pacific Land
TPL
$21.6B
| $724K | ﹤0.01% |
1,296
+60
| +5% | +$33.5K |
|
944
Vaxcyte
PCVX
$4.15B
| $722K | ﹤0.01% |
20,000
| – | – |
|
945
Webster Financial
WBS
$10.2B
| $713K | ﹤0.01% |
18,017
-17,147
| -49% | -$679K |
|
946
A10 Networks
ATEN
$1.26B
| $711K | ﹤0.01% |
47,750
| – | – |
|
947
Ligand Pharmaceuticals
LGND
$3.24B
| $708K | ﹤0.01% |
10,000
| – | – |
|
948
Xenon Pharmaceuticals
XENE
$2.86B
| $708K | ﹤0.01% |
20,000
| – | – |
|
|
JKS
949
JinkoSolar
JKS
$1.26B
| $703K | ﹤0.01% |
14,006
+4,945
| +55% | +$248K |
|
950
Immunocore
IMCR
$1.83B
| $698K | ﹤0.01% |
+15,000
| New | +$698K |
|